ArticleCHEST pulmonary2025

Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary Fibrosis.

Steven D Nathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.